tiprankstipranks
Grail up 4% to $18.84 after guidance in conference presentation
PremiumThe FlyGrail up 4% to $18.84 after guidance in conference presentation
15d ago
Grail: Patient-reported outcomes from PATHFINDER study published in Lancet
Premium
The Fly
Grail: Patient-reported outcomes from PATHFINDER study published in Lancet
17d ago
Booking initiated, Workday downgraded: Wall Street’s top analyst calls
Premium
The Fly
Booking initiated, Workday downgraded: Wall Street’s top analyst calls
2M ago
PremiumCompany AnnouncementsGrail Inc. Reports Strong Galleri Test Growth in Q3 2024
3M ago
Grail presents initial results from study of Galleri multi-cancer detection test
Premium
The Fly
Grail presents initial results from study of Galleri multi-cancer detection test
3M ago
Guggenheim starts Grail with Neutral on early stage of market
Premium
The Fly
Guggenheim starts Grail with Neutral on early stage of market
4M ago
Grail Inc trading resumes
PremiumThe FlyGrail Inc trading resumes
6M ago
Grail Inc trading halted, news pending
Premium
The Fly
Grail Inc trading halted, news pending
6M ago
Grail enrolls first participant in study of Galleri multi-cancer detection test
Premium
The Fly
Grail enrolls first participant in study of Galleri multi-cancer detection test
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100